Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836

EFFECT OF PHENYLBUTAZONE (3,5 DIOXO-1,2-DIPHENYL-4-n-BUTYLPYRAZOLIDINE) ON RENAL CLEARANCE OF URATE AND OTHER DISCRETE RENAL FUNCTIONS IN GOUTY SUBJECTS 1

Tsai Fan Yü 1,2, Jonas H Sirota 1,2,2, Alexander B Gutman 1,2
PMCID: PMC438451  PMID: 13108975

Full text

PDF
1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTHOUD E. L'influence de l'irgapyrine sur les fonctions rénales. Helv Med Acta. 1952 Oct;19(4-5):428–433. [PubMed] [Google Scholar]
  2. DUPONT P., DUCKERT-MAULBETSCH A., FABRE J. Modifications du metabolisme électrolytique et des fonctions glomérulaire et tubulaire sous l'influence des dérivés pyrazolés, irgapyrine et butazolidine. Helv Med Acta. 1952 Dec;19(6):528–546. [PubMed] [Google Scholar]
  3. GREEN J., WILLIAMS P. O. Effect of butazolidine on the excretion of water and electrolytes. Lancet. 1953 Mar 21;1(6760):575–577. doi: 10.1016/s0140-6736(53)91698-5. [DOI] [PubMed] [Google Scholar]
  4. GUTMAN A. B., YU T. F. Current principles of management in gout. Am J Med. 1952 Dec;13(6):744–759. doi: 10.1016/0002-9343(52)90374-4. [DOI] [PubMed] [Google Scholar]
  5. KIDD E. G., BOYCE K. C., FREYBERG R. H. Clinical studies of phenylbutazone (butazolidin) and butapyrin (irgapyrin) in rheumatoid arthritis, rheumatoid spondylitis, and gout. Ann Rheum Dis. 1953 Mar;12(1):20–24. doi: 10.1136/ard.12.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KUZELL W. C., SCHAFFARZICK R. W., BROWN B., MANKLE E. A. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout. J Am Med Assoc. 1952 Jun 21;149(8):729–734. doi: 10.1001/jama.1952.02930250011004. [DOI] [PubMed] [Google Scholar]
  7. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. WILKINSON E. L., BROWN H. The effect of butazolidin (phenylbutazone) on water and electrolyte excretion. Am J Med Sci. 1953 Feb;225(2):153–158. doi: 10.1097/00000441-195302000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES